Chlamidia Antibodies Test for Tubal Factor Screening

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT01406964

Enrollment

Registered

2011-08-01

Start date

2011-07-31

Completion date

2011-12-31

Last updated

2012-04-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sterility

Keywords

Chlamidia Antibody test, Hysterosalpyngography, Tubal disease

Brief summary

The aim of this study is to evaluate the usefulness of a Chlamydia Antibody Test for screening of tubal factor in patients who undergo artificial insemination.

Interventions

OTHERCAT test

A CAT test is performed in order to diagnose tubal factor causes

OTHERHisterosalpingography

A Histerosalpingography is performed.

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

DIAGNOSTIC

Masking

NONE

Eligibility

Sex/Gender

FEMALE

Age

18 Years to 38 Years

Healthy volunteers

Yes

Inclusion criteria

* Age \< 38 years * FSH \< 12. * Treatment intrauterine insemination

Exclusion criteria

* Insulin dependent diabetes * Thyroid disease * Severe male factor * Policystic ovarian syndrome * Previous abdominal or uterine surgery * Prevous abdominal or genital infections * Uterine myomas * Hidrosalpinx * Uterine congenital abnormalities

Design outcomes

Primary

Measure	Time frame	Description
Pregnancy outcome using the two different treatments.	6 months	Pregnancy rate, cumulative pregnancy rate and ectopic pregnancy rate in order to evaluate de usefulness of the CAT test as a predictor of tubal pathology.

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026